The Future of Pharma
Samir Gondalia, ISPE Boston
All episodes
Best episodes
Top 10 The Future of Pharma Episodes
Goodpods has curated a list of the 10 best The Future of Pharma episodes, ranked by the number of listens and likes each episode have garnered from our listeners. If you are listening to The Future of Pharma for the first time, there's no better place to start than with one of these standout episodes. If you are a fan of the show, vote for your favorite The Future of Pharma episode by adding your comments to the episode page.
Episode 22 - Nikhil Bhojwani and Using Generative AI in Pharmaceutical Industry without Irrational Fear
The Future of Pharma
05/07/24 • 31 min
My guest in this episode of The Future of Pharma is Nikhil Bhojwani.
Nikhil is an entrepreneur, investor, strategist, and TedTalk speaker. He is a Managing Partner at Recon Strategy, a boutique consulting firm that he founded in 2010. At Recon Strategy, Nikhil works with executives and boards on strategy at the portfolio and business-unit levels for payers, hospitals, life science, and digital health companies.
Nikhil stays close to the startup community as an investor, board member, and advisor to several companies. These have included CIC Health, a national leader in COVID testing and vaccinations, which was founded based on a blueprint set out in an HBR article Nikhil co-authored with Dr. Atul Gawande.
Nikhil was the 2023 Dorothy R. Eisenberg Visiting Professor at Harvard Medical School/ Brigham and Women's Hospital, where for the 50th anniversary lecture of this series, he presented a lecture on the future of AI in healthcare.
He has also lectured at Harvard Business School and the Harvard School of Public Health and is a member of the Massachusetts Governor's AI task force healthcare working group.
In this wide ranging talk, we discuss about - What AI can do that humans can't - How Moderna is using AI to respond to regulatory queries (among other things) - AI in pharma competitive landscape (and it's not just technology) - Where multiple big companies need to collaborate due to the scale - His tedtalk ("Unlock potential of Generative AI by Conquering the Spooky Mountain") - Responsible use of AI - Rational and irrational fears about AI - Why AI's growth seems scarier than other historical technological advances - Real impact in the pharmaceutical industry (and on the regulatory agencies) - And instead of writing a book, what he would do with the existing knowledge.
Hope you enjoy this informative talk with Nikhil Bhojwani.
Episode 18 - Gareth Shaw and Connecting Doctors and Patients in the 21st Century
The Future of Pharma
05/09/22 • 53 min
Gareth Shaw is the President, the UK & Europe of Doceree, the first global network of physician-only platforms for programmatic messaging. Prior to joining Doceree, Gareth was the General Manager, Global Programmatic, of PulsePoint where he led the programmatic and operations divisions.
Previously, he has held roles at Yahoo! and Experian.
Throughout his career, Gareth has gained vast experience in sales and operations across the digital media and advertising technology sectors. He has a well-regarded background in building high-performance teams and implementing strategic plans to facilitate the growth of his organizations.
Brian Hagopian, Water Purity and Rapid Bacteria Detection
The Future of Pharma
01/05/21 • 65 min
My guest today is Brian Hagopian who's known as or at least I call him "the Kevin Bacon of the Boston life sciences industry", either you know him or you know someone who knows him. He is currently the President of Clear Water Consulting, Inc.,and received his chemistry degree from Colgate University. He has over 35 years of design, manufacturing, and operational experience and is currently a highly sought after high purity water subject matter expert. Brian is an instructor at Worcester Polytechnic Institute and is also a Massachusetts certified instructor offering licensing courses for industrial wastewater operators. Brian is the Past President of the ISPE Boston Area Chapter where he helped to lay the foundation for the Boston Chapter’s highly successful Product Show at Gillette Stadium. Not surprisingly, Brian is one of six people to have received the Hank Moes Lifetime Achievement Award for significant contributions to the Boston chapter and the life sciences industry.
Some key takeaways from the interview. - Brian's dad was an entrepreneur - You have to be in the game to win it - We underestimate how much time and money everything’s going to take - When you're an entrepreneur, say goodbye to the 40 hours per week schedule - No matter your industry, it'll continue to evolve. You must try to keep up. - Being "thrifty business owner" got him to develop a new wastewater training course - Advice to Young Professional - avoid debt, plan for big expense in advance, use credit card only for emergencies, learn to negotiate, set goals and make plans to achieve them - His potential Ted talk - General water safety - Role models - Bill Russell (ex-Celtics player) - true team player, one of the greatest basketball players of all time - Books recommend to others - Outliers and Tipping Point by Malcolm Gladwell, Dale Carnegie public speaking course - it helps with a lot more than just public speaking, Thinking Fast and Slow by Daniel Kahneman - Quote he lives by - The harder I work, the luckier I get (the world is full of brilliant but lazy underachievers)
For me, he's been a friend and a mentor. In this interview, we talk about his beginning as an entrepreneur and all the excitement and challenges that come with that, how the industry has changed over the years and where it's headed. You'll also hear some nuggets about how to build your professional career, develop new skills and why hard work will outperform everything else every time. Hope you enjoy this talk from a very generous individual who's always given more than he has received. Here's Brian Hagopian.
Episode 13 - Francesca McBride, Cell Therapy and Global Regulations
The Future of Pharma
01/13/21 • 51 min
My guest today is Francesca McBride. Francesca completed a Bachelor of Science Degree at the University of Delaware in 1985, majoring in Pre-Veterinary Science. As a pharmaceutical/ biotechnology regulatory compliance specialist Francesca works with international companies to support the design, start-up, licensing and operation of clinical and commercial product manufacturing facilities.
She has been with Jacobs (Pharmaceuticals and Biotechnology) for 25+ years and currently in her capacity as a Director, Regulatory Compliance is involved in the support of client and design teams to ensure the design meets the applicable international cGMP / cGTP requirements.
During her tenure at Jacobs she has lived and worked in the US, UK, Ireland and India. She has both presented and published papers at global conferences.
Most recently she has worked with hospitals and universities in the design and startup of new cell therapy facilities that support the treatment of cancer. Francesca's goal is to build a stronger relationship with the cell therapy facilities to advance the cancer treatment opportunities - an area which is very close to her heart and you'll understand why after listening to her story. Last but not least, she's also a Triathlete.
Some takeaways from the interview - Francesca's global journey - Say yes to new opportunities - When a new technology is introduced, everyone's learning at the same time - Regulatory 101 lesson - Which regulations apply during which stage of the drug development - How regulatory agencies' approach have changed over the years - How different regulatory agencies differ - Regulatory Dos and Don'ts at the beginning of a project - Advice for young women: Research careers to match your interest, Develop your expertise - Impact of a good professor on a student - Book she keeps going back to (given to her by her sister) : The Red Tent by Anita Diamant
Enjoy this interview with Francesca and listen how she simplifies the complicated global regulations around the life sciences for us to understand. Here's Francesca McBride.
Episode 5 - Blockchain and Fake Drugs with Dr. Hariawala, Prof Vaishnav and Mr. Mankodi
The Future of Pharma
06/04/19 • 28 min
Dr. Mukesh Hariawala is a world-renowned heart surgeon, a highly sought after keynote speaker and Chairman of American Healthcare International (AHI). Prof Chintan Vaishnav is a professor at Sloan School of Management at MIT and Director of MIT Tata Center for Technology and Design. Mr. Jayesh Mankodi is an IT industry veteran with expertise in Infrastructure Architecture and Cloud Computing. Chintan and Jayesh are advisors to AHI. Using blockchain technology and cloud computing, Mukesh, Chintan and Jayesh at AHI are working to solve the problem of fake drugs in the market.
Episode 4 - Continuous Manufacturing and Rare Events with Prof Bernhardt Trout
The Future of Pharma
03/11/19 • 26 min
Episode 4 - Continuous Manufacturing and Rare Events with Prof Bernhardt Trout
Professor Trout directs the Molecular Engineering Laboratory and Novartis-MIT Center for Continuous Manufacturing at Massachusetts Institute of Technology, Cambridge, MA. He is considered one of the pioneers to pave the way for the continuous manufacturing in the highly complex and regulated field of the pharmaceutical manufacturing. Find out his thoughts on how continuous manufacturing and rare events will affect the future of the pharmaceutical industry in this chat with Samir Gondalia.
Episode 6 - Matt Roberge and the Global Pharma Forces
The Future of Pharma
03/03/20 • 53 min
My guest today is Matt Roberge. He got his Mechanical engg degree from Villanova Uni. He currently works for Pfizer and serves as a senior director of Global technology network and Emerging market. He has a truly global organization with teams in the USA, china, russia, argentina, brazil, india and i'm sure i'm forgetting a couple. I had the pleasure of working under Matt's leadership when Pfizer built the first Asian Biologics Development Center in Hangzhou, China few years back. We had a great time recording this interview. Hope you enjoy it too. Here's Matt Roberge from Pfizer.
Episode 1: Nanoparticles and the future of implants with Prof. Tom Webster
The Future of Pharma
11/10/18 • 28 min
Visit ispeboston.org for complete show notes of every Podcast episode.
Professor Webster directs the Webster Nanomedicine Laboratory at Northeastern University, Boston which designs, synthesizes, and evaluates nanomaterials for various implant applications. To date, his lab group has generated over 9 textbooks, 48 book chapters, 306 invited presentations, at least 403 peer-reviewed literature articles, at least 567 conference presentations, and 32 provisional or full patents. Some of these patents led to the formation of 9 companies. Find out his thoughts on how nanoparticles will affect the future of the pharmaceutical industry in this chat with Samir Gondalia.
Episode 0 - Welcome to the Future of Pharma!
The Future of Pharma
10/11/18 • 3 min
The introductory episode to launch our Podcast - The Future of Pharma with ISPE Boston. Learn about the podcast, ISPE Boston and the host, Samir Gondalia and why it's a must subscription for a pharma professional.
Episode 24 - Dr. Samuel Ewing and the New World of Digital Hospitals
The Future of Pharma
07/31/24 • 36 min
My guest in this episode is Dr. Samuel Ewing. He is the Global Head of Pharmaceutical Partnerships at Doccla.
Before joining Doccla, Dr. Ewing led the development of a connected auto-injector system for Roche’s Alzheimer’s disease program at Capgemini Engineering. He also led the development of Biofourmis’s wearable vital sign monitoring platform.
At Roche, he managed remote patient monitoring across various diseases, including Parkinson’s, Huntington’s, Alzheimer’s, Multiple Sclerosis, and others. As Chief Neuroscience Officer at NeuroPro, he developed a wearable brain monitoring device for epilepsy.
Dr. Ewing's extensive experience in digital health and medical research drives his commitment to advancing treatment for challenging diseases. He believes that the scarcity of data from patients in the real world hinders progress, something he is committed to overcoming.
In this fascinating chat, we talk about our current hospital systems, and capacity, and how patients can get the hospital care in the comfort of their home in a digital hospital.
Here’s my guest Dr. Samuel Ewing.
Show more best episodes
Show more best episodes
FAQ
How many episodes does The Future of Pharma have?
The Future of Pharma currently has 28 episodes available.
What topics does The Future of Pharma cover?
The podcast is about Health & Fitness, Pharma, Boston, Medicine, Podcasts, Science, Pharmaceutical, Innovation and Healthcare.
What is the most popular episode on The Future of Pharma?
The episode title 'Episode 20 - Hon. Prof. Tom Chittenden and the Potential and Challenges of AI in the Pharmaceutical Industry' is the most popular.
What is the average episode length on The Future of Pharma?
The average episode length on The Future of Pharma is 39 minutes.
How often are episodes of The Future of Pharma released?
Episodes of The Future of Pharma are typically released every 43 days, 2 hours.
When was the first episode of The Future of Pharma?
The first episode of The Future of Pharma was released on Oct 11, 2018.
Show more FAQ
Show more FAQ